サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1659436

整形外科軟部組織修復術の世界市場

Orthopedic Soft Tissue Repair

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
整形外科軟部組織修復術の世界市場
出版日: 2025年02月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

整形外科軟部組織修復術の世界市場は2030年までに121億米ドルに達する見込み

2024年に88億米ドルと推定される整形外科軟部組織修復術の世界市場は、2024年から2030年にかけてCAGR 5.6%で成長し、2030年には121億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるCruciate Ligaments Repair Procedureは、CAGR 7.2%を記録し、分析期間終了時には56億米ドルに達する見込みです。腱板修復術セグメントの成長率は、分析期間中CAGR 4.0％と推定されます。

米国市場は24億米ドルと推定、中国はCAGR5.1％で成長予測

米国の整形外科軟部組織修復術市場は2024年に24億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに19億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.4％と4.3％と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界の整形外科軟部組織修復術市場- 主要動向と促進要因のまとめ

整形外科軟部組織修復術がスポーツ傷害や変性疾患の治療に不可欠な理由とは？

整形外科軟部組織修復術は、特にスポーツへの参加や身体活動が世界的に増加し続ける中、様々な怪我や変性疾患の治療において非常に重要となっています。腱、靭帯、軟骨などの軟部組織は、関節を安定させ、動きを円滑にする上で重要な役割を担っていますが、反復運動や外傷、加齢に伴う変性による傷害の影響を非常に受けやすくなっています。腱板断裂、ACL断裂、半月板損傷など、これらの構造物の損傷は、アスリートや活動的な人の間で一般的であり、完治には外科的介入が必要となることが多いです。整形外科軟部組織修復術技術-低侵襲の関節鏡手術からより高度な生物学的療法まで-は、機能を回復し、痛みを軽減し、長期的な損傷を防ぐための効果的な解決策を提供します。これらの重要な構造を修復・補強することにより、整形外科軟部組織修復術は患者様の可動性、筋力、生活の質の回復をサポートします。

スポーツ関連傷害の増加により、整形外科軟部組織修復術はスポーツ医学の焦点となっています。腱や靭帯の再建、軟骨の修復、半月板の修復といった手技は、急性および慢性の傷害に対処するために広く用いられており、患者は再傷害のリスクを減らしながら活動に復帰することができます。例えば、ACL再建術は、膝の安定性が重要な競技スポーツでは一般的な手技です。この手術では、断裂した靭帯を移植片で置換し、膝の機能を回復させる。同様に、腱板修復手術は、オーバーヘッド運動をする人によく行われ、時間の経過とともに腱の摩耗や断裂を引き起こす可能性があります。スポーツへの参加やフィットネスに対する意識が高まるにつれ、迅速で安全な回復をサポートする専門的な軟部組織修復技術に対する需要も高まっています。

スポーツ傷害の治療に加え、整形外科軟部組織修復術は、腱症、椎間板変性症、変形性関節症など、高齢者がよく罹患する加齢関連疾患への対応にも不可欠です。加齢とともに軟部組織は弾力性と回復力を失い、断裂や変性が起こりやすくなります。腱移植、軟骨移植、低侵襲関節鏡検査などの軟部組織修復技術は、これらの症状の治療、痛みの軽減、可動性の回復に効果的な選択肢を提供します。急性の損傷と慢性の変性の両方に対処することで、整形外科軟部組織修復術は加齢による関節機能と生活の質への影響を軽減し、あらゆる年齢層の人々にとって包括的な整形外科治療の不可欠な側面として位置づけられています。

整形外科軟部組織修復術市場は、生物学的療法とイノベーションによってどのように前進しているのでしょうか？

整形外科軟部組織修復術市場は、治癒の促進や治療成績の向上を目指す生物学的療法や技術革新の台頭によって大きな影響を受けています。多血小板血漿（PRP）、幹細胞療法、自家軟骨細胞移植（ACI）などの生物学的療法は、損傷した軟部組織の修復・再生に新たなアプローチを提供します。患者自身の血液から血小板を濃縮するPRPは、成長因子によって組織の修復を促進するために損傷部位に注入されます。幹細胞療法は、幹細胞を用いて損傷した組織を再生する可能性があり、腱板断裂や軟骨損傷などの症状に有望な選択肢を提供します。これらの生物学的治療は、身体の自然治癒プロセスを促進することで、回復時間を短縮し、組織修復の質を向上させる可能性のある、従来の修復方法に代わる治療法です。生物学的療法が普及するにつれ、より早い回復と傷跡の軽減を求める患者の要望に応える低侵襲の再生オプションを提供することで、軟部組織修復の展望を再構築しつつあります。

生物学的療法に加え、手術技術とインプラント材料の革新が、整形外科軟部組織修復術.関節鏡手術の進歩を牽引しています。小型カメラと特殊な器具を使用する関節鏡手術は、外科医が小さな切開創から軟部組織を修復することを可能にし、外傷を減らして回復を早める。この手技は肩、膝、股関節の修復によく用いられ、患者の入院期間を短縮し、活動への復帰を早める。軟部組織を骨に再接着するための縫合糸アンカーの技術革新も、こうした修復の効果を高めています。最新の縫合糸アンカーは、固定強度と生体吸収性を向上させるよう設計されており、追加処置の必要性を減らしています。生体吸収性アンカーや全縫合糸アンカーは時間の経過とともに溶解するため、長期的な合併症を最小限に抑え、自然治癒をサポートします。低侵襲手技と生体親和性材料が整形外科手術の標準となるにつれ、これらの技術革新は外科医に、成功し長持ちする修復を達成するためのより良い手段を提供しています。

さらに、組織工学や合成移植片は、特に複雑で大規模な損傷に対する有望なソリューションとして台頭してきています。ポリウレタンやポリカプロラクトンなどの材料から作られた合成移植片は、天然組織の構造と機能を模倣し、細胞の成長と組織の再生をサポートする足場を提供します。例えば、腱や靭帯の修復において、合成移植片は、自家移植片や同種移植片が利用できない場合の代替となり、組織の統合をサポートし、関節の安定性を向上させる。また、合成素材と生物学的製剤を組み合わせた組織工学技術も開発中であり、合成素材の強度と生物学的組織の再生可能性を融合させたハイブリッド移植片の作成を目指しています。このような先進的な素材と技術は、課題となっている傷害の治療に新たな選択肢を提供し、軟部組織修復の範囲を広げ、整形外科市場に新たな可能性を切り開くものです。

外科医と患者にとっての整形外科軟部組織修復術の利点とは？

整形外科軟部組織修復術は、外科医と患者の双方に多くの利点をもたらし、複雑な損傷に対する効果的な治療を可能にすると同時に、より早く安全な回復を促します。外科医にとっての第一の利点は、正確で低侵襲な処置によって関節の安定性と機能性を回復できることです。小さな切開創から修復を可能にする関節鏡技術により、外科医は損傷した組織を可視化し、周辺構造への損傷を最小限に抑えて治療することができます。このアプローチは手術の精度を高め、合併症のリスクを軽減し、外科医が大きな切開をすることなく特定の損傷に対処することを可能にします。このような低侵襲技術は、ACL断裂や腱板損傷などの一般的なスポーツ傷害の治療において特に有用であり、標的を絞った修復を行うことで、より良い治療成績と患者の早期回復が期待できます。高度な画像診断と専門的なツールを使用することで、外科医は関節の可動性と機能を完全に回復させるために不可欠な、精度の高い修復を行うことができます。

患者にとって、整形外科軟部組織修復術は、痛みの緩和、可動性の回復、長期的な関節の健康という点で大きな利益をもたらします。軟部組織の損傷は、放置しておくと慢性的な痛み、関節の不安定性、日常生活や身体活動に影響を及ぼす機能的制限につながります。軟部組織修復技術によって損傷した腱、靭帯、軟骨を修復することで、患者は関節の安定性を取り戻し、痛みを軽減し、通常の活動に戻ることができます。腱再建や靭帯修復などの処置は、損傷した関節の強度と柔軟性を回復させ、再受傷のリスクを減らし、長期的な健康をサポートします。アスリートや活動的な人々にとって、軟部組織の修復はより早いリハビリを可能にし、自信を持ってスポーツや運動に復帰することを可能にします。さらに、このような傷害に早期に対処することで、軟部組織の修復は関節変性の進行を防ぐのに役立ち、関節炎を引き起こし、後に侵襲的な手術が必要になることもあります。

もうひとつの重要な利点は、治癒力を高め、回復時間を短縮できる生物学的・再生的アプローチに重点を置いていることです。PRPや幹細胞注射のような生物学的療法は、身体の自然な修復機構と一緒に働く選択肢を患者に提供し、多くの場合、瘢痕が少なくなり、組織の質が改善されます。これらの再生技術は、スポーツ選手や肉体的に過酷な仕事をする人など、身体的要求の高い患者や、より早い回復を必要とする患者にとって特に有益です。軟部組織修復における生物学的製剤の使用は、より自然な治癒プロセスをサポートするだけでなく、低侵襲で患者に優しい治療に対する需要の高まりにも合致しています。生物学的療法と低侵襲技術の進歩により、整形外科軟部組織修復術は患者により安全で効率的な回復経路を提供し、全体的な治療経験と治療成績を向上させています。

整形外科軟部組織修復術市場の成長を促進しているものは？

整形外科軟部組織修復術市場の成長は、スポーツ傷害の発生率の増加、高齢化、生物学的療法や低侵襲性療法の進歩、患者中心の治療結果の重視の高まりなどの要因によってもたらされます。スポーツやレクリエーション活動が世界中で盛んになるにつれ、ACL断裂、腱板損傷、半月板損傷などのスポーツ関連傷害の発生率が著しく上昇しています。これらの損傷は外科的介入を必要とすることが多く、効果的で耐久性のある解決策を可能にする特殊な軟部組織修復技術に対する高い需要が生まれています。整形外科軟部組織修復術は、このような需要に応えるために必要なツールとテクニックを提供し、アスリートや活動的な人々の完全回復と活動への復帰を支援します。さらに、フィットネスやウェルネスの動向の人気の高まりに伴い、軟部組織損傷のリスクを高めるような身体活動に参加する人が増えており、市場の需要をさらに促進しています。

人口の高齢化も、整形外科軟部組織修復術市場の成長に寄与する大きな要因です。高齢になると、腱症、変形性関節症、靭帯の劣化など、軟部組織に影響を及ぼす退行性疾患にかかりやすくなります。高齢者は、可動性を回復し、痛みを軽減し、自立を維持するために、軟部組織の修復処置を必要とすることが多いです。腱板修復や軟骨修復のような処置は、この層では特に一般的で、加齢による変性に対処し、高齢者が活動的でいられるよう支援します。平均寿命が延びるにつれて、晩年における関節の健康と可動性をサポートするソリューションの必要性が高まり、軟部組織修復の需要が高まり続けています。ヘルスケア・プロバイダーと患者が、高齢になっても活動的なライフスタイルと高い生活の質を維持することを優先するため、この動向は拡大すると予想されます。

また、生物学的治療や低侵襲治療の台頭も、整形外科軟部組織修復術市場を押し上げています。これらの進歩は、侵襲性が低く、より効率的な治療オプションを提供し、回復までの時間も短縮するためです。PRPや幹細胞治療のような生物学的治療は、軟部組織の治癒を促進し、回復期間を短縮する可能性が認められつつあり、最新の再生ソリューションを求める患者の期待に応えています。外科医が小切開で精密な修復を行うことを可能にする関節鏡技術の拡大は、回復時間を短縮し患者の快適性を向上させる低侵襲的アプローチに対する需要と一致しています。こうした革新的な治療法や技術は、効果的な結果をもたらすだけでなく、患者の転帰を改善することに重点を置くヘルスケア・プロバイダーにとっても魅力的です。スポーツ傷害の増加、高齢化、生物学的製剤と低侵襲手術の進歩といったこれらの要因が相まって、整形外科軟部組織修復術市場は成長を牽引しており、現代の整形外科・スポーツ医学における重要な分野として位置付けられています。

セグメント

手技（十字靭帯修復術、腱板修復術、上顆炎、アキレス腱伸筋症修復術、骨盤臓器脱、股関節鏡、その他の手技）;傷害部位（膝、肩、股関節、小関節）

調査対象企業の例（合計 42注目）

  • Artelon
  • Arthrex
  • ConMed
  • DePuy Synthes
  • Integra LifeSciences
  • JRF Ortho
  • LifeNet Health
  • Medtronic
  • MTF Biologics
  • Parcus Medical
  • RTI Surgical
  • Smith & Nephew
  • Stryker
  • Tissue Regenix
  • Wright Medical
  • Zimmer Biomet

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22439

Global Orthopedic Soft Tissue Repair Market to Reach US$12.1 Billion by 2030

The global market for Orthopedic Soft Tissue Repair estimated at US$8.8 Billion in the year 2024, is expected to reach US$12.1 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cruciate Ligaments Repair Procedure, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Rotator Cuff Repair Procedure segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 5.1% CAGR

The Orthopedic Soft Tissue Repair market in the U.S. is estimated at US$2.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.4% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Orthopedic Soft Tissue Repair Market - Key Trends & Drivers Summarized

Why Is Orthopedic Soft Tissue Repair Essential in Treating Sports Injuries and Degenerative Conditions?

Orthopedic soft tissue repair has become critical in treating a wide range of injuries and degenerative conditions, especially as sports participation and physical activity continue to rise globally. Soft tissues, including tendons, ligaments, and cartilage, play an essential role in stabilizing joints and facilitating movement, yet they are highly susceptible to injuries from repetitive motion, trauma, and age-related degeneration. Injuries to these structures, such as rotator cuff tears, ACL ruptures, and meniscal damage, are common among athletes and active individuals and often require surgical intervention for full recovery. Orthopedic soft tissue repair techniques—ranging from minimally invasive arthroscopic surgeries to more advanced biological therapies—offer effective solutions for restoring function, reducing pain, and preventing long-term damage. By repairing and reinforcing these critical structures, orthopedic soft tissue repair supports patients in regaining mobility, strength, and quality of life.

The rising incidence of sports-related injuries has made orthopedic soft tissue repair a focal point in sports medicine, where quick and effective recovery is essential for athletes and active individuals. Procedures like tendon and ligament reconstruction, cartilage repair, and meniscal repair are widely used to address acute and chronic injuries, allowing patients to return to their activities with reduced risk of re-injury. For example, ACL reconstruction is a common procedure in competitive sports, where knee stability is crucial. This procedure uses grafts to replace the torn ligament and restore knee function, often enabling athletes to resume their performance levels. Similarly, rotator cuff repair surgeries are frequently performed in individuals who engage in overhead activities, which can lead to tendon wear and tears over time. As sports participation and fitness awareness grow, so does the demand for specialized soft tissue repair techniques that support fast, safe recovery.

In addition to treating sports injuries, orthopedic soft tissue repair is essential in addressing age-related conditions like tendinopathy, degenerative disc disease, and osteoarthritis, which commonly affect older adults. With age, soft tissues lose elasticity and resilience, making them more prone to tears and degeneration. Soft tissue repair techniques, including tendon transfers, cartilage grafting, and minimally invasive arthroscopy, provide effective options for treating these conditions, reducing pain, and restoring mobility. By addressing both acute injuries and chronic degeneration, orthopedic soft tissue repair helps mitigate the impact of aging on joint function and quality of life, positioning it as an essential aspect of comprehensive orthopedic care for people of all ages.

How Are Biological Therapies and Innovations Advancing the Orthopedic Soft Tissue Repair Market?

The orthopedic soft tissue repair market has been significantly influenced by the rise of biological therapies and technological innovations that aim to enhance healing and improve outcomes. Biological therapies, such as platelet-rich plasma (PRP), stem cell therapy, and autologous chondrocyte implantation (ACI), offer new approaches for repairing and regenerating damaged soft tissues. PRP, which involves concentrating platelets from the patient’s own blood, is injected into the injured area to promote tissue repair through growth factors. Stem cell therapy uses stem cells to potentially regenerate damaged tissue, offering a promising option for conditions like rotator cuff tears and cartilage damage. These biologic treatments provide an alternative to traditional repair methods by enhancing the body’s natural healing processes, potentially reducing recovery times and improving the quality of tissue repair. As biological therapies gain traction, they are reshaping the soft tissue repair landscape by providing minimally invasive, regenerative options that meet patient demand for faster recovery and reduced scarring.

In addition to biological therapies, innovations in surgical techniques and implant materials have driven advancements in orthopedic soft tissue repair. Arthroscopic surgery, which involves the use of a small camera and specialized instruments, allows surgeons to repair soft tissues through tiny incisions, reducing trauma and accelerating recovery. This technique is commonly used for shoulder, knee, and hip repairs, offering patients shorter hospital stays and quicker returns to activity. Innovations in suture anchors, which are used to reattach soft tissues to bone, have also enhanced the effectiveness of these repairs. Modern suture anchors are designed for improved fixation strength and bioabsorption, reducing the need for additional procedures. Bioabsorbable anchors and all-suture anchors dissolve over time, minimizing long-term complications and supporting natural healing. As minimally invasive techniques and bio-friendly materials become standard in orthopedic surgeries, these innovations are providing surgeons with better tools to achieve successful and lasting repairs.

Furthermore, tissue engineering and synthetic grafts are emerging as promising solutions for orthopedic soft tissue repair, particularly for complex or large-scale injuries. Synthetic grafts made from materials like polyurethane and polycaprolactone mimic the structure and function of natural tissues, providing scaffolding that supports cell growth and tissue regeneration. For example, in tendon and ligament repairs, synthetic grafts offer an alternative when autografts or allografts are not available, supporting tissue integration and improving joint stability. Tissue engineering techniques that combine synthetic materials with biologics are also under development, with the aim of creating hybrid grafts that blend the strength of synthetics with the regenerative potential of biological tissues. These advanced materials and techniques provide new options for treating challenging injuries, expanding the scope of soft tissue repair and opening up new opportunities in the orthopedic market.

What Are the Benefits of Orthopedic Soft Tissue Repair for Surgeons and Patients?

Orthopedic soft tissue repair offers numerous benefits for both surgeons and patients, enabling effective treatment of complex injuries while promoting faster and safer recovery. For surgeons, the primary advantage is the ability to restore joint stability and functionality through precise, minimally invasive procedures. Arthroscopic techniques, which allow repairs through small incisions, enable surgeons to visualize and treat damaged tissues with minimal disruption to surrounding structures. This approach improves surgical precision, reduces the risk of complications, and allows surgeons to address specific injuries without extensive incisions. These minimally invasive techniques are especially valuable in treating common sports injuries, such as ACL tears and rotator cuff damage, where targeted repairs lead to better outcomes and faster patient recovery. By using advanced imaging and specialized tools, surgeons can achieve highly accurate repairs, which is essential for restoring full joint mobility and function.

For patients, orthopedic soft tissue repair provides significant benefits in terms of pain relief, mobility restoration, and long-term joint health. Soft tissue injuries, if left untreated, can lead to chronic pain, joint instability, and functional limitations that affect daily life and physical activity. Repairing damaged tendons, ligaments, and cartilage through soft tissue repair techniques enables patients to regain joint stability, reduce pain, and return to their regular activities. Procedures such as tendon reconstruction and ligament repair help restore the strength and flexibility of the injured joint, reducing the risk of re-injury and supporting long-term health. For athletes and active individuals, soft tissue repair allows for quicker rehabilitation, enabling them to return to sports and exercise with confidence. Additionally, by addressing these injuries early on, soft tissue repair helps prevent the progression of joint degeneration, which can lead to arthritis and the need for more invasive surgeries later.

Another crucial benefit is the focus on biologic and regenerative approaches, which can enhance healing and reduce recovery times. Biological therapies like PRP and stem cell injections provide patients with options that work alongside the body’s natural repair mechanisms, often resulting in less scarring and improved tissue quality. These regenerative techniques are particularly beneficial for patients with high physical demands or those who require a faster recovery, such as athletes or individuals with physically demanding jobs. The use of biologics in soft tissue repair not only supports a more natural healing process but also aligns with the growing demand for minimally invasive, patient-friendly treatments. With advancements in biologic therapies and minimally invasive techniques, orthopedic soft tissue repair offers patients safer, more efficient recovery paths that improve overall treatment experiences and outcomes.

What Is Fueling the Growth in the Orthopedic Soft Tissue Repair Market?

The growth in the orthopedic soft tissue repair market is driven by factors such as the increasing incidence of sports injuries, the aging population, advancements in biologic and minimally invasive therapies, and a growing emphasis on patient-centered outcomes. As sports and recreational activities become more popular worldwide, the incidence of sports-related injuries, such as ACL tears, rotator cuff injuries, and meniscal damage, has risen significantly. These injuries often require surgical intervention, creating a high demand for specialized soft tissue repair techniques that enable effective, durable solutions. Orthopedic soft tissue repair provides the tools and techniques needed to meet this demand, helping athletes and active individuals recover fully and return to their activities. Additionally, with the increased popularity of fitness and wellness trends, more people are participating in physical activities that increase their risk of soft tissue injuries, further fueling the market demand.

The aging population is another major factor contributing to the growth of the orthopedic soft tissue repair market. As people age, they are more susceptible to degenerative conditions that affect soft tissues, such as tendinopathy, osteoarthritis, and ligament degradation. Older adults often require soft tissue repair procedures to restore mobility, reduce pain, and maintain independence. Procedures like rotator cuff repair and cartilage restoration are particularly common in this demographic, addressing age-related degeneration and helping older individuals stay active. As life expectancy increases, the need for solutions that support joint health and mobility in later years continues to drive demand for soft tissue repair. This trend is expected to grow as healthcare providers and patients prioritize maintaining an active lifestyle and high quality of life throughout aging.

The rise of biologic and minimally invasive therapies has also boosted the orthopedic soft tissue repair market, as these advancements offer less invasive, more efficient treatment options with quicker recovery times. Biological treatments such as PRP and stem cell therapy are increasingly recognized for their potential to enhance soft tissue healing and reduce recovery durations, meeting the expectations of patients seeking modern, regenerative solutions. The expansion of arthroscopic techniques, which allow surgeons to perform precise repairs through small incisions, aligns with the demand for minimally invasive approaches that reduce recovery time and improve patient comfort. These innovative therapies and techniques not only offer effective results but also appeal to healthcare providers focused on improving patient outcomes. Together, these factors—rising sports injuries, the aging population, and advancements in biologics and minimally invasive surgery—are driving the growth of the orthopedic soft tissue repair market, positioning it as a critical area within modern orthopedic and sports medicine.

SCOPE OF STUDY:

The report analyzes the Orthopedic Soft Tissue Repair market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Procedure (Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy, Other Procedures); Injury Location (Knee, Shoulder, Hip, Small Joints)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Artelon
  • Arthrex
  • ConMed
  • DePuy Synthes
  • Integra LifeSciences
  • JRF Ortho
  • LifeNet Health
  • Medtronic
  • MTF Biologics
  • Parcus Medical
  • RTI Surgical
  • Smith & Nephew
  • Stryker
  • Tissue Regenix
  • Wright Medical
  • Zimmer Biomet

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Orthopedic Soft Tissue Repair - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Sports-Related Injuries Drives Soft Tissue Repair Market
    • Growing Preference for Minimally Invasive Surgeries Sets the Stage for Market Growth
    • Innovations in Biodegradable Implants Propel Demand for Soft Tissue Repair Solutions
    • Increasing Demand for Arthroscopic Procedures Expands Market Potential
    • Advancements in Biomaterials Propel Soft Tissue Repair Technologies
    • Rising Geriatric Population Generates Demand for Soft Tissue Repair Solutions
    • Increasing Use in Rotator Cuff Repair Expands Addressable Market
    • Growing Demand for Cartilage Repair Solutions Drives Market Growth
    • Increasing Investments in Sports Medicine Propel Soft Tissue Repair Demand
    • Soft Tissue Repair Crucial for Treatment of Tendon and Ligament Injuries
    • Use of Soft Tissue Repair in Trauma Surgeries Bodes Well for Market Expansion
    • Demand for Biocompatible Repair Materials Sets the Stage for Market Growth
    • Expanding Applications in Gynecological, and Urological Surgeries
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Orthopedic Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Orthopedic Soft Tissue Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cruciate Ligaments Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cruciate Ligaments Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Cruciate Ligaments Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Rotator Cuff Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Rotator Cuff Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Rotator Cuff Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Epicondylitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Epicondylitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Epicondylitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Achilles Tendinosis Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Achilles Tendinosis Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Achilles Tendinosis Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pelvic Organ Prolapsed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pelvic Organ Prolapsed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Pelvic Organ Prolapsed by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hip Arthroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hip Arthroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hip Arthroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Hip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Small Joints by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Small Joints by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Small Joints by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Knee by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Shoulder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Shoulder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Shoulder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Orthopedic Soft Tissue Repair Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • JAPAN
    • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • CHINA
    • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • EUROPE
    • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Orthopedic Soft Tissue Repair by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Orthopedic Soft Tissue Repair by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • FRANCE
    • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • GERMANY
    • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Orthopedic Soft Tissue Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Orthopedic Soft Tissue Repair by Procedure - Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Orthopedic Soft Tissue Repair by Procedure - Percentage Breakdown of Value Sales for Cruciate Ligaments Repair, Rotator Cuff Repair, Epicondylitis, Achilles Tendinosis Repair, Pelvic Organ Prolapsed, Hip Arthroscopy and Other Procedures for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Orthopedic Soft Tissue Repair by Injury Location - Hip, Small Joints, Knee and Shoulder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of World 15-Year Perspective for Orthopedic Soft Tissue Repair by Injury Location - Percentage Breakdown of Value Sales for Hip, Small Joints, Knee and Shoulder for the Years 2015, 2025 & 2030

IV. COMPETITION